-
41
-
42
Anti-SARS-CoV-2 Antibody Level among Renal Transplant Recipients: A Case Report from Nepal
Published 2022-01-01“…All three cases had received two doses of Oxford-AstraZeneca COVID-19 vaccine AZD1222 (ChAdOx1). Serological analysis showed protective level of circulating antibodies in the blood of all three cases. …”
Get full text
Article -
43
-
44
-
45
Differential Cytotoxicity Responses by Dog and Rat Hepatocytes to Phospholipogenic Treatments
Published 2013-01-01Get full text
Article -
46
-
47
-
48
Thrombosis with thrombocytopenia after first dose of ChAdOx1 nCoV-19 vaccine: a case report
Published 2021-12-01“…However, several cases of acute thrombotic events with thrombocytopenia after receiving ChAdOx1 nCoV-19 (AstraZeneca (Vaxzevria)) vaccine have been published. …”
Get full text
Article -
49
Cigarette Smoke Suppresses the Surface Expression of c-kit and FcεRI on Mast Cells
Published 2013-01-01Get full text
Article -
50
-
51
The Influence of Differences in Solvents and Concentration on the Efficacy of Propofol at Induction of Anesthesia
Published 2016-01-01“…The patients of group D1 received AstraZeneca Diprivan 1% (Osaka, Japan) at a rate of 40 mg kg−1 h−1. …”
Get full text
Article -
52
-
53
Papel del Estado en la campaña de vacunación contra la COVID-19 a través del ordenamiento jurídico
Published 2024-04-01“…Durante el proceso de emergencia, las vacunas que aprobaron las autoridades para la población fueron las Pfizer-BioNTech, Moderna, Sputnik, Jhonson & Jhonson, AstraZeneca, Sinopharm, Sinovac, Covaxin y Covocax. …”
Get full text
Article -
54
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer
Published 2025-02-01Get full text
Article -
55
Role of Fcγ receptors in HER2-targeted breast cancer therapy
Published 2022-01-01Get full text
Article -
56
Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients
Published 2025-02-01“…However, there are few studies on the efficacy of the ChAdOx1 nCoV-19 (AstraZeneca) vaccine compared between various immunosuppressive regimens. …”
Get full text
Article -
57
Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer
Published 2025-01-01“…Results We report the therapeutic potential of combining panobinostat (pan-HDAC inhibitor) with AZD7762 (CHK1/2 inhibitor; AstraZeneca) or ionizing radiation (IR) to re-sensitize RR-HNC cells and showed increased DNA damage underlying enhanced synergy. …”
Get full text
Article -
58
-
59
-
60